These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1970782)

  • 21. Pharmacokinetics of morphine and its surrogates. III: Morphine and morphine 3-monoglucuronide pharmacokinetics in the dog as a function of dose.
    Garrett ER; Jackson AJ
    J Pharm Sci; 1979 Jun; 68(6):753-71. PubMed ID: 458581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic study of the enterohepatic circulation of acetaminophen glucuronide in rats.
    Watari N; Hanawa M; Iwai M; Kaneniwa N
    J Pharmacobiodyn; 1984 Nov; 7(11):811-9. PubMed ID: 6530646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A practical method for monitoring drug excretion and enterohepatic circulation in the rat.
    Tse FL; Ballard F; Jaffe JM
    J Pharmacol Methods; 1982 Mar; 7(2):139-44. PubMed ID: 7098496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation.
    Steimer JL; Plusquellec Y; Guillaume A; Boisvieux JF
    J Pharm Sci; 1982 Mar; 71(3):297-302. PubMed ID: 7069584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enterohepatic circulation of methotrexate in rats in vivo.
    Steinberg SE; Campbell CL; Bleyer WA; Hillman RS
    Cancer Res; 1982 Apr; 42(4):1279-82. PubMed ID: 7060005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enterohepatic recirculation of the new antihypertensive drug UP 269-6 in humans. A possible model to account for multiple plasma peaks.
    Plusquellec Y; Arnaud R; Saivin S; Shepard TA; Carrie I; Hermann P; Souhait J; Houin G
    Arzneimittelforschung; 1998 Feb; 48(2):138-44. PubMed ID: 9541723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversible cholestasis induced by bromosulfophthalein in rabbits with enterohepatic circulation of bile acids maintained.
    Jiménez R; Larrubia O; Monte MJ; Gonzalez J; Esteller A
    Biomed Biochim Acta; 1988; 47(2):141-7. PubMed ID: 2845961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiologically motivated time-delay model to account for mechanisms underlying enterohepatic circulation of piroxicam in human beings.
    Tvrdonova M; Dedik L; Mircioiu C; Miklovicova D; Durisova M
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):35-42. PubMed ID: 18713233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiologic and metabolic influences on enterohepatic recirculation: simulations based upon the disposition of valproic acid in the rat.
    Pollack GM; Brouwer KL
    J Pharmacokinet Biopharm; 1991 Apr; 19(2):189-225. PubMed ID: 2013839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatic clearance of drugs. Physiological and pharmacokinetic considerations].
    Pellegrin P; Lesne M
    J Pharmacol; 1983; 14(2):107-39. PubMed ID: 6865443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats.
    Fukuyama T; Yamaoka K; Ohata Y; Nakagawa T
    Drug Metab Dispos; 1994; 22(3):479-85. PubMed ID: 8070327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biliary excretion and enterohepatic cycling of zearalenone in immature pigs.
    Biehl ML; Prelusky DB; Koritz GD; Hartin KE; Buck WB; Trenholm HL
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):152-9. PubMed ID: 8337696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biliary excretion of drugs in man.
    Rollins DE; Klaassen CD
    Clin Pharmacokinet; 1979; 4(5):368-79. PubMed ID: 389528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biliary excretion of drugs and other xenobiotics.
    Levine WG
    Annu Rev Pharmacol Toxicol; 1978; 18():81-96. PubMed ID: 348071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Excretion of drugs in bile in man].
    Terhaag B
    Pharmazie; 1980; 35(10):638-9. PubMed ID: 7454747
    [No Abstract]   [Full Text] [Related]  

  • 36. Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulation.
    Tse FL; Ballard F; Skinn J
    J Pharmacokinet Biopharm; 1982 Aug; 10(4):455-61. PubMed ID: 7153875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of methylergometrine in the rat: evidence for enterohepatic recirculation by a linked-rat model.
    Bredberg U; Paalzow L
    Pharm Res; 1990 Jan; 7(1):14-20. PubMed ID: 2300530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.
    Moriwaki T; Yasui H; Yamamoto A
    J Pharmacokinet Pharmacodyn; 2003 Apr; 30(2):119-44. PubMed ID: 12942684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enterohepatic circulation of glucuronide metabolites of drugs in dog.
    Zhou X; Cassidy KC; Hudson L; Mohutsky MA; Sawada GA; Hao J
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00502. PubMed ID: 31333846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. General treatment of the enterohepatic recirculation of drugs and its influence on the area under the plasma level curves, bioavailability, and clearance.
    Peris-Ribera JE; Torres-Molina F; Garcia-Carbonell MC; Aristorena JC; Granero L
    Pharm Res; 1992 Oct; 9(10):1306-13. PubMed ID: 1448431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.